Mod­er­na dou­bles down on rare dis­eases; FDA ad­vi­so­ry com­mit­tee votes on fall Covid cam­paign; Il­lu­mi­na CEO steps down; ...

3 years ago
Weekly

Mer­ck clos­es $10.8B deal with Prometheus

3 years ago
R&D

In­dia man­u­fac­tur­er En­zene choos­es New Jer­sey for US lo­ca­tion

3 years ago
Manufacturing

Ab­b­Vie's Phar­ma­cyclics files patent suit against BeiGene over BTK ri­val Brukin­sa

3 years ago
Pharma
Law

Eli Lil­ly’s mi­graine pre­ven­tion drug Em­gal­i­ty not su­pe­ri­or to Pfiz­er’s Nurtec ODT in head-to-head

3 years ago
R&D
Pharma

House Re­pub­li­cans use FDA ap­pro­pri­a­tions bill to over­ride REMS changes on abor­tion pill

3 years ago
FDA+
Law

Bi­par­ti­san group of sen­a­tors calls for ways to im­prove 340B drug dis­count pro­gram

3 years ago
Pharma

Cannes Li­ons en­tries for phar­ma, health & well­ness awards sig­nal re­turn to busi­ness as usu­al

3 years ago
Pharma
Marketing

Drug­mak­ers seek clar­i­ty from FDA on man­u­fac­tur­ing in­ter­rup­tion no­ti­fi­ca­tions

3 years ago
FDA+
Manufacturing

Keytru­da com­bi­na­tion hits pri­ma­ry end­point in a rare form of gas­tric can­cer

3 years ago
R&D

All aboard the pub­lic fi­nanc­ing train! Zen­tal­is, Ed­i­tas, Ve­rastem, Prax­is and Clene, among oth­ers, raise funds

3 years ago
Financing

Co­herus to buy Sur­face On­col­o­gy in stock deal val­ued at $65M

3 years ago
People
Deals

Twist Bio­science lays off 212 staffers, most­ly in San Fran­cis­co

3 years ago
R&D

Ex-Metacrine chief Pre­ston Klassen recharges at mi­croR­NA biotech; Al­lo­gene be­gins search for a CFO

3 years ago
Peer Review

FDA ap­proves Roche’s sec­ond CD20xCD3 bis­pe­cif­ic in cer­tain lym­phomas

3 years ago
R&D
Pharma

FDA de­lays de­ci­sion on GSK blood can­cer drug at heart of $1.9B Sier­ra On­col­o­gy deal

3 years ago
R&D
Pharma

As­traZeneca en­lists an up­start Chi­na biotech part­ner in the wake of an R&D set­back

3 years ago
Deals
Bioregnum

Con­gress in­tro­duces two new bills about PBM re­form, drug pric­ing

3 years ago
Pharma
Law

VRB­PAC unan­i­mous­ly rec­om­mends mono­va­lent, XBB lin­eage for next fal­l's Covid-19 vac­cine cam­paign

3 years ago
FDA+
Coronavirus

Ab­b­Vie touts Skyrizi ul­cer­a­tive col­i­tis da­ta as it eyes an­oth­er in­di­ca­tion

3 years ago
Pharma

No­vo Nordisk boosts an­ti-obe­si­ty stig­ma ef­forts with film and TV doc­u­men­tary part­ner­ships

3 years ago
Pharma
Marketing

Ab­b­Vie steps up to the plate with MLB play­er for IBD aware­ness

3 years ago
Pharma
Marketing

Prime Med­i­cine con­sid­ers fo­cus on au­toim­mune dis­eases for CAR-T, CEO says

3 years ago
R&D
Cell/Gene Tx

Co­herus and Ab­b­Vie set­tle Hu­mi­ra biosim­i­lar dis­pute af­ter Mark Cuban's Cost Plus Drugs an­nounce­ment

3 years ago
Pharma
First page Previous page 325326327328329330331 Next page Last page
A service from the Financial Times